Clinical Trial Update: Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of Harvoni (ledipasvir/sofosbuvir) in adults with Genotype 1 hepatitis C who are alcoholics; completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: University of Nebraska | Conditions: Genotype 1 Hepatitis C Virus | Phase 4 | Status: COMPLETED | Results posted: 2023-02-23